» Articles » PMID: 10644787

An Ambulatory Dyskinesia Monitor

Overview
Date 2000 Jan 25
PMID 10644787
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: New treatments are now becoming available for the management of levodopa induced dyskinesias in Parkinsons's disease. However, assessment of their efficacy is limited by the inadequacies of current methods of dyskinesia measurement. The objective was to develop and validate a portable device capable of objectively measuring dyskinesias during normal daily activities.

Methods: A portable device was developed based on a triaxial accelerometer, worn on the shoulder, and a data recorder that can record levodopa induced dyskinesias. A computer program plots raw acceleration and acceleration over 0.5 Hz frequency bands against time. The acceleration in the different bands can then be compared with the raw acceleration trace, enabling identification and exclusion of confounding activities such as tremor and walking, which have a characteristic appearance on the trace. The validity of this device was assessed on 12 patients and eight age matched controls by comparing accelerations in the 1-3 Hz frequency band with established clinical dyskinesia rating scales. While wearing the monitor, subjects were videorecorded sitting and during dyskinesia provocation tasks, including mental activation tasks, eating, drinking, writing, putting on a coat, and walking. The dyskinesias were graded with both modified abnormal involuntary movement (AIM) and Goetz scales. The clinical ratings were then compared with the mean acceleration scores.

Results: Acceleration in the 1-3 Hz frequency band correlated well against both scales, during all individual tasks. Acceleration produced by normal voluntary activity (with the exception of walking, which produced large accelerations, even in controls) was small compared with dyskinetic activity. With walking excluded, the mean acceleration over the rest of the recording time correlated strongly with both the modified AIM (Spearman's rank (r=0.972, p<0.001) and Goetz (r=0.951, p<0.001) scales.

Conclusions: This method provides an accurate, objective means for dyskinesia assessment, and compares favourably with established methods currently used.

Citing Articles

Unveiling the Unpredictable in Parkinson's Disease: Sensor-Based Monitoring of Dyskinesias and Freezing of Gait in Daily Life.

Zampogna A, Borzi L, Rinaldi D, Artusi C, Imbalzano G, Patera M Bioengineering (Basel). 2024; 11(5).

PMID: 38790307 PMC: 11117481. DOI: 10.3390/bioengineering11050440.


A New Paradigm in Parkinson's Disease Evaluation With Wearable Medical Devices: A Review of STAT-ON.

Rodriguez-Martin D, Cabestany J, Perez-Lopez C, Pie M, Calvet J, Sama A Front Neurol. 2022; 13:912343.

PMID: 35720090 PMC: 9202426. DOI: 10.3389/fneur.2022.912343.


Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson's disease motor symptoms.

Chandrabhatla A, Pomeraniec I, Ksendzovsky A NPJ Digit Med. 2022; 5(1):32.

PMID: 35304579 PMC: 8933519. DOI: 10.1038/s41746-022-00568-y.


Estimating dyskinesia severity in Parkinson's disease by using a waist-worn sensor: concurrent validity study.

Rodriguez-Molinero A, Perez-Lopez C, Sama A, Rodriguez-Martin D, Alcaine S, Mestre B Sci Rep. 2019; 9(1):13434.

PMID: 31530855 PMC: 6748910. DOI: 10.1038/s41598-019-49798-3.


Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.

Delamarre A, Tison F, Li Q, Galitzky M, Rascol O, Bezard E J Neural Transm (Vienna). 2019; 126(6):789-793.

PMID: 31098725 DOI: 10.1007/s00702-019-02015-x.


References
1.
Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

2.
Golbe L, Pae J . Validity of a mailed epidemiological questionnaire and physical self-assessment in Parkinson's disease. Mov Disord. 1988; 3(3):245-54. DOI: 10.1002/mds.870030309. View

3.
Nutt J . Levodopa-induced dyskinesia: review, observations, and speculations. Neurology. 1990; 40(2):340-5. DOI: 10.1212/wnl.40.2.340. View

4.
van Hilten J, Middelkoop H, Kerkhof G, Roos R . A new approach in the assessment of motor activity in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1991; 54(11):976-9. PMC: 1014619. DOI: 10.1136/jnnp.54.11.976. View

5.
van Hilten J, Kabel J, Middelkoop H, Kramer C, Kerkhof G, Roos R . Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring. Acta Neurol Scand. 1993; 87(3):171-7. DOI: 10.1111/j.1600-0404.1993.tb04096.x. View